Georgia health system files copied by hackers
Tift Regional Health System has experienced a data breach, with an unauthorized party accessing or copying files containing patient information.
Stay updated with breaking news from Aug 16. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tift Regional Health System has experienced a data breach, with an unauthorized party accessing or copying files containing patient information.
SPRUCE HEAD — The Craignair Gallery invites the public to the opening reception of Maine: The Way Light Should Be by Thomaston artist Kevin Beers on Wednesday, August 16, from 4 to 7 p.m. “Beers’ masterful oil paintings capture the remarkable ever-...
STOCKTON SPRINGS — “How can you not love a Pie-Palooza?” said Sandy Point Community Club, in a news release. “Who would not rejoice in a bountiful, rich, and delectable array of both sweet and savory pies?” The Sandy Point Community Club will hold a...
SEATTLE, Aug. 16, 2022 /PRNewswire/ -- Quark Expeditions, the global Leader in Polar Adventures, has expanded its overnight camping opportunities for guests in Greenland as part of this season's portfolio of immersive experiences. "Camping overnight in the Polar Regions has long captured the imaginations of our guests," says Thomas Lennartz, Vice-President of Sales for Quark Expeditions. "We launched our first camping options in Antarctica, where guests could bed down for the night while gazing up at the indigo glow of an Antarctic night. Antarctic Camping has been such a hu...
ATG-018, a global rights asset developed by Antengene's internal R&D team, is an orally-bioavailable, small molecule ataxia telangiectasia and Rad3-associated (ATR) kinase inhibitor that targets the DNA damage response (DDR) pathways. The Phase I study will evaluate the safety, pharmacology and preliminary efficacy of ATG-018 monotherapy in patients with advanced tumors and hematologic malignancies. SHANGHAI and HONG KONG, Aug. 16, 2022 /PRNewswire/ --Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical com...